ANGIODYNAMICS INC
ANGO · Surgical & Medical Instruments & Apparatus · 41.3M shares · +1%/yr ↑ dilution · EDGAR filings ↗
Reference price $11.81 · est. market cap ~$488M — last insider purchase, 2025-10-21 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D48Medical-device company (vascular/oncology devices) with operating losses and cash burn.
Strengths
- Liquidity — current ratio 2.2 (40th)
Risks
- Operating/net losses & cash burn — per metrics
- declining revenue (-4%) and ongoing portfolio transition — per 10-K
- Adoption/reimbursement dependence — per 10-K
Notable findings
- FDA recallFDA recall (Class II) — Soft-Vu Angiographic Catheter, Kumpe, Non-Braided; SOFT-VU KMP 4F X 65CM 038 NB (2026-03-03)
- Net lossNet loss (net margin -11.6%)
- Cash burnNegative free cash flow (-14.6M)
- Exec changeRecent 8-K item 5.02 8-K ↗
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- FDA approvalFDA clearance/approval — AlphaVac Multipurpose Mechanical Aspiration System F1885 (2025-11-24)
- Notable holderHeld by 5 notable fund(s): STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC +2 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
53.9%
Operating margin
-13.7%
Net margin
-11.6%
Return on equity
-18.6%
Return on assets
-12.1%
Revenue growth (QoQ)
-1.3%
Current ratio
2.2×
Free cash flow
-$15M
EBITDA
-$14M
Tangible book value
$114M
Cash & investments
$56M
Cash runway
15q
Stock comp / revenue
3.3%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2025-10-21 | Weiss Lawrence T | Buy | 10K | $11.81 |
| 2025-10-13 | Trowbridge Stephen A | Buy | 890 | $11.16 |
| 2025-10-09 | Clemmer James C | Buy | 10K | $11.15 |
| 2025-07-21 | Nighan Warren JR | Tax withheld | 277 | $8.99 |
| 2025-07-21 | Campbell Chad Thomas | Tax withheld | 395 | $8.99 |
| 2025-07-21 | Trowbridge Stephen A | Tax withheld | 667 | $8.99 |
| 2025-07-20 | Campbell Chad Thomas | Tax withheld | 359 | $8.69 |
| 2025-07-20 | Trowbridge Stephen A | Tax withheld | 717 | $8.69 |
| 2025-07-20 | Piccinini Laura | Tax withheld | 616 | $8.69 |
| 2025-07-20 | Nighan Warren JR | Tax withheld | 251 | $8.69 |
| 2025-07-20 | Clemmer James C | Tax withheld | 3.0K | $8.69 |
| 2025-07-20 | Clemmer James C | Tax withheld | 3.7K | $8.99 |
| 2025-07-19 | Clemmer James C | Tax withheld | 8.3K | $8.69 |
| 2025-07-19 | Campbell Chad Thomas | Tax withheld | 1.0K | $8.69 |
| 2025-07-19 | Piccinini Laura | Tax withheld | 2.0K | $8.69 |
| 2025-07-19 | Trowbridge Stephen A | Tax withheld | 2.6K | $8.69 |
| 2025-07-19 | Nighan Warren JR | Tax withheld | 735 | $8.69 |
| 2025-07-19 | Clemmer James C | Tax withheld | 344 | $8.69 |
| 2025-07-17 | Piccinini Laura | Tax withheld | 3.1K | $8.74 |
| 2025-07-16 | Piccinini Laura | Grant | 32K | — |
| 2025-07-16 | Nighan Warren JR | Grant | 29K | — |
| 2025-07-16 | Clemmer James C | Grant | 206K | — |
| 2025-07-16 | Weiss Lawrence T | Grant | 31K | — |
| 2025-07-16 | Trowbridge Stephen A | Grant | 87K | — |
| 2025-07-16 | Campbell Chad Thomas | Grant | 26K | — |
| 2025-07-16 | DONNELLY HOWARD W | Grant | 18K | — |
| 2025-07-16 | Burgess Lorinda | Grant | 18K | — |
| 2025-07-16 | Auen Eileen O'Shea | Grant | 18K | — |
| 2025-07-16 | JOHNSON WESLEY | Grant | 18K | — |
| 2025-07-16 | Tarnoff Michael E | Grant | 18K | — |
| 2025-07-16 | REED JAN STERN | Grant | 18K | — |
| 2025-07-16 | Licitra Karen A | Grant | 18K | — |
| 2025-01-16 | Nighan Warren JR | Sell | 4.1K | $12.31 |
All non-derivative Form 4 activity (SEC), newest first.
Clinical trials
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT06777901 ↗ | Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone Peripheral Arterial Diseases | PHASE4 | Recruiting | 2029-02-01 |
| NCT06697314 ↗ | Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System Acute Pulmonary Embolism (PE), Pulmonary Embolism | NA | Recruiting | 2028-06-01 |
| NCT07280247 ↗ | Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness Pulmonary Embolism Acute | NA | Recruiting | 2026-12-01 |
| NCT03899636 ↗ | A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer Stage III Pancreatic Cancer | PHASE3 | Active Not Recruiting | 2025-04-01 |
| NCT03899649 ↗ | A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer Stage III Pancreatic Cancer | — | Active Not Recruiting | 2025-04-01 |
| NCT07472439 ↗ | Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone in Europe Peripheral Arterial Disease | NA | Not Yet Recruiting | 2029-05-01 |
| NCT07191548 ↗ | International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE Colorectal Adenocarcinoma Metastatic in the Liver, Liver Ablation | NA | Not Yet Recruiting | 2028-02-01 |
| NCT07192731 ↗ | International Study on Treatment of Liver (HCC) Patients With IRE Hepatocellular Carcinoma (HCC), Liver Ablation | NA | Not Yet Recruiting | 2028-02-01 |
| NCT07640776 ↗ | Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH) Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH) | NA | Not Yet Recruiting | 2027-12-01 |
| NCT07282002 ↗ | Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis Infective Endocarditis (IE) | NA | Not Yet Recruiting | 2026-11-01 |
| NCT04972097 ↗ | Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue Prostate Cancer | NA | Completed | 2024-08-14 |
| NCT05318092 ↗ | Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism Pulmonary Embolism, Acute Pulmonary Embolism | NA | Completed | 2024-01-04 |
| NCT01972867 ↗ | Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients Prostate Cancer | NA | Unknown | 2022-11-01 |
| NCT04229563 ↗ | Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease Infrainguinal Peripheral Artery Disease, Peripheral Arterial Disease | — | Completed | 2021-03-17 |
| NCT02215369 ↗ | SeCure Endovenous Laser Treatment Study Chronic Venous Insufficiency | NA | Completed | 2018-03-01 |
| NCT02775565 ↗ | Initial Experience With the AngioVac Venous Drainage Cannula Heart Disease | — | Completed | 2016-09-01 |
| NCT01921114 ↗ | The PROOF Study: The PICC Related Obstruction Of Flow Study Patients Indicated for a PICC for Any Medical Condition | NA | Terminated | 2014-07-01 |
| NCT01078415 ↗ | Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC) Carcinoma, Hepatocellular | NA | Completed | 2013-01-01 |
| NCT01369420 ↗ | NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer Pancreatic Adenocarcinoma | PHASE2 | Completed | 2011-12-01 |
| NCT01064895 ↗ | Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE) Acute Kidney Injury, Acute Renal Failure | — | Terminated | 2011-12-01 |
Source: ClinicalTrials.gov (U.S. NIH) · active studies first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-04-23 | Other | filing ↗ |
| 2026-04-02 | ResultsReg FDExhibits | filing ↗ |
| 2026-02-03 | Exec/director changeExhibits | filing ↗ |
| 2026-01-14 | Reg FDExhibits | filing ↗ |
| 2026-01-06 | ResultsReg FDExhibits | filing ↗ |
| 2025-11-12 | Shareholder vote | filing ↗ |
| 2025-10-02 | ResultsReg FDExhibits | filing ↗ |
| 2025-07-15 | ResultsReg FDExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-04-23 | 2026-04-23 | 0001140361-26-016424 ↗ |
| 8-K | 2026-04-02 | 2026-04-02 | 0001140361-26-012891 ↗ |
| 10-Q | 2026-04-02 | 2026-02-28 | 0001628280-26-023008 ↗ |
| 8-K | 2026-02-03 | 2026-01-30 | 0001140361-26-003518 ↗ |
| 8-K | 2026-01-14 | 2026-01-14 | 0001140361-26-001154 ↗ |
| 8-K | 2026-01-06 | 2026-01-06 | 0001140361-26-000341 ↗ |
| 10-Q | 2026-01-06 | 2025-11-30 | 0001275187-26-000003 ↗ |
| 8-K | 2025-11-12 | 2025-11-10 | 0001140361-25-041542 ↗ |
| 8-K | 2025-10-02 | 2025-10-02 | 0001140361-25-037060 ↗ |
| 10-Q | 2025-10-02 | 2025-08-31 | 0001628280-25-043689 ↗ |
| 10-K | 2025-07-18 | 2025-05-31 | 0001275187-25-000014 ↗ |
| 8-K | 2025-07-15 | 2025-07-15 | 0001140361-25-025835 ↗ |